Breaking News Instant updates and real-time market news.

CCK

Crown Holdings

$59.31

0.14 (0.24%)

, VNOM

Viper Energy

$19.95

-0.11 (-0.55%)

10:31
11/29/17
11/29
10:31
11/29/17
10:31

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) downgraded to Hold after Broadcom bid at Stifel with analyst Kevin Cassidy arguing the risk in the shares is now greater than the potential reward following the company's recent rejection of Broadcom's (AVGO) $70 per share bid. 2. Paccar (PCAR) downgraded to Neutral from Buy at Citi with analyst Timothy Thein saying he no longer sees catalysts in place to warrant a Buy rating. 3. Colgate-Palmolive (CL) downgraded to Sell from Hold at Societe Generale with analyst Iain Simpson saying Colgate's new focus on investing aggressively in both price and A&P is the right move, but believes consensus is underestimating how long it will take to yield positive results and how much it will cost. 4. Chipotle (CMG) downgraded to Market Perform from Outperform at William Blair with analyst Sharon Zackfia citing the announcement that its founder and CEO Steve Ells will step down following the completion of a search to identify a new CEO. While a new leader may accelerate the company's turnaround longer term, today's move likely signals that Chipotle's trends remain under pressure and creates more near-term uncertainty, Zackfia tells investors in a research note. 5. MAA (MAA) downgraded to Market Perform from Outperform at Raymond James with analyst Buck Horne saying a material acceleration of construction in MAA's core submarkets will create near-term headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CCK

Crown Holdings

$59.31

0.14 (0.24%)

VNOM

Viper Energy

$19.95

-0.11 (-0.55%)

ROLL

RBC Bearings

$126.86

1.7 (1.36%)

ACMR

ACM Research

$6.80

-0.1 (-1.45%)

INVH

Invitation Homes

$23.11

0.03 (0.13%)

  • 05

    Dec

CCK Crown Holdings
$59.31

0.14 (0.24%)

07/21/17
VERT
07/21/17
DOWNGRADE
Target $64
VERT
Hold
Crown Holdings downgraded to Hold from Buy at Vertical Research
Vertical Research analyst Chip Dillon downgraded Crown Holdings to Hold citing recent share strength and raised its price target to $64 from $60.
11/29/17
UBSW
11/29/17
INITIATION
Target $65
UBSW
Neutral
Crown Holdings initiated with a Neutral at UBS
UBS analyst Edlain Rodriguez started Crown Holdings with a Neutral rating and $65 price target. The analyst views the stock's risk/reward as "fairly balanced" at current levels.
02/06/17
VERT
02/06/17
UPGRADE
Target $60
VERT
Buy
Crown Holdings upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Chip Dillon upgraded Crown Crown Holdings to Buy and raised its price target to $60 from $58 citng valuation.
VNOM Viper Energy
$19.95

-0.11 (-0.55%)

11/29/17
RHCO
11/29/17
INITIATION
Target $29
RHCO
Buy
Viper Energy initiated with a Buy at SunTrust
SunTrust analyst Neal Dingmann started Viper Energy Partners LP with a Buy rating and $29 price target. The company offers a "unique way to play Permian growth combined with solid oil prices," the analyst contends.
08/23/17
MZHO
08/23/17
UPGRADE
Target $28
MZHO
Buy
Viper Energy upgraded to Buy from Neutral at Mizuho
Mizuho analyst Tim Rezvan upgraded Viper Energy to Buy and increased its price target to $28 from $17 to reflect long-term production and cash flow growth, and balance sheet strength.
10/02/17
UBSW
10/02/17
INITIATION
Target $18
UBSW
Neutral
Viper Energy initiated with a Neutral at UBS
UBS analyst Shneur Gershuni started Viper Energy Partners LP with a Neutral rating and $18 price target.
10/02/17
10/02/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Micron (MU) initiated with a Market Perform at BMO Capital. 2. Virtu Financial (VIRT) initiated with an In Line at Evercore ISI. 3. Viper Energy (VNOM) initiated with a Neutral at UBS. 4. Trade Desk (TTD) and Criteo (CRTO) were initiated with an Outperform at JMP Securities. 5. Myomo (MYO) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ROLL RBC Bearings
$126.86

1.7 (1.36%)

12/12/16
WBLR
12/12/16
UPGRADE
WBLR
Outperform
RBC Bearings upgraded to Outperform from Market Perform at William Blair
11/28/17
KING
11/28/17
INITIATION
Target $142
KING
Buy
RBC Bearings initiated with a Buy at CL King
CL King initiated RBC Bearings with a Buy rating and $142 price target, citing the company's accelerating revenue growth, expanding operating margins and rising book-to-bill ratio.
ACMR ACM Research
$6.80

-0.1 (-1.45%)

11/29/17
ROTH
11/29/17
INITIATION
Target $10
ROTH
Buy
ACM Research initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva started ACM Research with a Buy rating and $10 price target. The company is well positioned in the semiconductor capital equipment market, specifically targeting the single wafer wet cleaning equipment opportunity, the analyst contends. He believes ACM can steadily gain market share.
INVH Invitation Homes
$23.11

0.03 (0.13%)

11/29/17
DBAB
11/29/17
INITIATION
Target $26
DBAB
Buy
Invitation Homes resumed with a Buy at Deutsche Bank
Deutsche Bank analyst Vin Chao resumed coverage of Invitation Homes with a Buy rating and $26 price target. The analyst favors the company over multifamily REITs citing a more favorable fundamental backdrop.
11/27/17
EVER
11/27/17
INITIATION
Target $25.5
EVER
Outperform
Invitation Homes resumed with an Outperform at Evercore ISI
Evercore ISI analyst Steve Sakwa resumed coverage on Invitation Homes with an Outperform and $25.50 price target.
10/09/17
BTIG
10/09/17
INITIATION
Target $26
BTIG
Buy
Invitation Homes initiated with a Buy at BTIG
BTIG analyst Ryan Gilbert started Invitation Homes (INVH) with a Buy rating and $26 price target, as he believes it can grow core FFO 17% in 2018 on a combination of internal and external growth opportunities and synergies from its the Starwood Waypoint (SFR) merger.
08/14/17
KBWI
08/14/17
UPGRADE
Target $25
KBWI
Outperform
Invitation Homes upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Jade Rahmani upgraded Invitation Homes (INVH) to Outperform following the Q2 results and an analysis of the Starwood Waypoint Homes (SFR) merger. The analyst raised Invitation's price target to $25 from $23.

TODAY'S FREE FLY STORIES

ADBE

Adobe

$175.00

-1.83 (-1.03%)

07:15
12/15/17
12/15
07:15
12/15/17
07:15
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$3.57

-0.15 (-4.03%)

07:14
12/15/17
12/15
07:14
12/15/17
07:14
Initiation
Rigel Pharmaceuticals initiated  »

Cantor sees FDA approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

CRTO

Criteo

$24.42

-7.19 (-22.75%)

07:12
12/15/17
12/15
07:12
12/15/17
07:12
Downgrade
Criteo rating change  »

Criteo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

07:11
12/15/17
12/15
07:11
12/15/17
07:11
Recommendations
Oracle analyst commentary  »

Oracle business momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$22.60

2.28 (11.22%)

07:10
12/15/17
12/15
07:10
12/15/17
07:10
Hot Stocks
Innovative Industrial Properties raises quarterly dividend to 25c per share »

Innovative Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$42.96

-0.72 (-1.65%)

07:08
12/15/17
12/15
07:08
12/15/17
07:08
Recommendations
Hologic analyst commentary  »

Hologic positioned well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFGC

Performance Food Group

$30.55

-0.9 (-2.86%)

07:07
12/15/17
12/15
07:07
12/15/17
07:07
Earnings
Performance Food Group sees FY18 adjusted EPS up 13%-18% »

For fiscal 2018, PFG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

TYME

Tyme Technologies

$3.30

0.05 (1.54%)

07:05
12/15/17
12/15
07:05
12/15/17
07:05
Initiation
Tyme Technologies initiated  »

Tyme Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

, SNY

Sanofi

$43.09

-0.83 (-1.89%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Hot Stocks
Alnylam announces lift of FDA clinical hold on Fitusiran »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

SNY

Sanofi

$43.09

-0.83 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

UA

Under Armour; also tag UAA

$12.45

0.09 (0.73%)

, UAA

Under Armour; also tag UA

$13.82

0.2 (1.47%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Upgrade
Under Armour; also tag UAA, Under Armour; also tag UA rating change  »

Under Armour upgraded to…

UA

Under Armour; also tag UAA

$12.45

0.09 (0.73%)

UAA

Under Armour; also tag UA

$13.82

0.2 (1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBA

Ritchie Bros.

$28.69

0.3 (1.06%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Hot Stocks
Ritchie Bros. sess $50M+ of equipment in final Fort Worth, TX auction of 2017 »

This week Ritchie Bros.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$43.09

-0.83 (-1.89%)

, ALNY

Alnylam

$123.66

-1.2 (-0.96%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
Sanofi says FDA lifts clinical hold on fitusiran »

Sanofi Genzyme, the…

SNY

Sanofi

$43.09

-0.83 (-1.89%)

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

CROX

Crocs

$10.94

-0.34 (-3.01%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Upgrade
Crocs rating change  »

Crocs upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

ESNC

EnSync

$0.44

0.0663 (17.79%)

, CHTR

Charter

$328.68

-0.32 (-0.10%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
EnSync: Spectrum solar plus storage project commissioned in Hawaii »

EnSync (ESNC) announces…

ESNC

EnSync

$0.44

0.0663 (17.79%)

CHTR

Charter

$328.68

-0.32 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

PFGC

Performance Food Group

$30.55

-0.9 (-2.86%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
Performance Food Group appoints Jim Hope as CFO »

Performance Food Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

07:02
12/15/17
12/15
07:02
12/15/17
07:02
Hot Stocks
Aclaris Therapeutics receives FDA approval for Eskata topical solution, 40% »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

AER

AerCap

$52.12

-0.46 (-0.87%)

07:01
12/15/17
12/15
07:01
12/15/17
07:01
Recommendations
AerCap analyst commentary  »

AerCap book value can hit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTWO

Q2 Holdings

$37.30

-0.75 (-1.97%)

07:00
12/15/17
12/15
07:00
12/15/17
07:00
Recommendations
Q2 Holdings analyst commentary  »

Q2 Holdings has strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

07:00
12/15/17
12/15
07:00
12/15/17
07:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.82

-0.2 (-2.85%)

06:59
12/15/17
12/15
06:59
12/15/17
06:59
Downgrade
Fitbit rating change  »

Fitbit downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,174.80

10.61 (0.91%)

06:55
12/15/17
12/15
06:55
12/15/17
06:55
Periodicals
Luxembourg appeals EU order to recover tax from Amazon, Reuters reports »

Luxembourg is appealing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

06:55
12/15/17
12/15
06:55
12/15/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Aclaris Therapeutics »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

GDX

Market Vector Gold Miners

$22.07

-0.09 (-0.41%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$110.57

2.96 (2.75%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Recommendations
Disney, 21st Century Fox analyst commentary  »

Disney price target…

DIS

Disney

$110.57

2.96 (2.75%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

GLD

SPDR Gold Trust

$118.93

-0.24 (-0.20%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.